Ryan Martin's most recent trade in 89bio Inc was a trade of 8,498 Common Stock done at an average price of $9.6 . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.62 per share. | 12 Jun 2025 | 8,498 | 261,176 (1%) | 0% | 9.6 | 81,751 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.57 per share. | 17 Feb 2025 | 780 | 269,674 (1%) | 0% | 10.6 | 8,245 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.41 per share. | 09 Feb 2025 | 3,828 | 270,454 (1%) | 0% | 11.4 | 43,677 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 80,000 | 277,620 (2%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.60 per share. | 01 Feb 2025 | 3,338 | 274,282 (1%) | 0% | 9.6 | 32,045 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 95,000 | 197,620 (1%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 09 Sep 2024 | 3,212 | 102,620 (0%) | 0% | 8.5 | 27,174 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.04 per share. | 17 Aug 2024 | 777 | 105,832 (0%) | 0% | 8.0 | 6,247 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share. | 17 Feb 2024 | 778 | 106,609 (0%) | 0% | 9.7 | 7,578 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.45 per share. | 09 Feb 2024 | 3,568 | 107,387 (0%) | 0% | 8.5 | 30,150 | Common Stock |
| 89bio Inc | Martins Ryan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Martins Ryan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 48,750 | 111,847 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.80 per share. | 01 Feb 2024 | 892 | 110,955 (0%) | 0% | 9.8 | 8,742 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 15,000 | 69,221 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.53 per share. | 05 Jan 2024 | 6,124 | 63,097 (0%) | 0% | 11.5 | 70,610 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.61 per share. | 09 Sep 2023 | 2,074 | 54,221 (0%) | 0% | 16.6 | 34,449 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.46 per share. | 01 Aug 2023 | 753 | 56,295 (0%) | 0% | 15.5 | 11,641 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.64 per share. | 01 Aug 2023 | 346 | 57,048 (0%) | 0% | 15.6 | 5,411 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 5,834 | 59,412 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.95 per share. | 30 Jun 2023 | 2,018 | 57,394 (0%) | 0% | 18.9 | 38,241 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.95 per share. | 04 Apr 2023 | 8,721 | 53,578 (0%) | 0% | 15.0 | 130,379 | Common Stock |
| Fathom Digital Manufacturi... | Ryan Martin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 661,013 | 661,013 | - | - | Stock Options | |
| Fathom Digital Manufacturi... | Ryan Martin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 352,540 | 2,034,116 | - | - | Class A Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 7,500 | 64,893 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 5,833 | 59,411 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. | 31 Mar 2023 | 2,594 | 62,299 (0%) | 0% | 15.2 | 39,507 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. | 31 Mar 2023 | 2,018 | 57,393 (0%) | 0% | 15.2 | 30,734 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 23 Mar 2023 | 5,000 | 53,578 (0%) | 0% | 16.1 | 80,550 | Common Stock |
| Fathom Digital Manufacturi... | Ryan Martin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 08 Mar 2023 | 10,189 | 1,681,576 | - | 1.2 | 12,257 | Class A Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 17 Feb 2023 | 2,540 | 58,578 (0%) | 0% | 13.9 | 35,281 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.97 per share. | 17 Feb 2023 | 1,750 | 61,118 (0%) | 0% | 14.0 | 24,448 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 30,000 | 62,868 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.41 per share. | 08 Feb 2023 | 1,480 | 32,868 (0%) | 0% | 14.4 | 21,327 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 3,000 | 81,901 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.11 per share. | 03 Feb 2023 | 3,000 | 38,960 (0%) | 0% | 13.1 | 39,330 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.11 per share. | 03 Feb 2023 | 3,000 | 38,960 (0%) | 0% | 3.1 | 9,330 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.24 per share. | 03 Feb 2023 | 592 | 34,348 (0%) | 0% | 13.2 | 7,838 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 03 Feb 2023 | 592 | 35,368 (0%) | 0% | 12.7 | 7,518 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.05 per share. | 01 Feb 2023 | 408 | 35,960 (0%) | 0% | 12.0 | 4,916 | Common Stock |
| Fathom Digital Manufacturi... | Ryan Martin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.43 per share. | 27 Jan 2023 | 66,263 | 1,691,765 | - | 1.4 | 94,756 | Class A Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 03 Jan 2023 | 5,947 | 36,368 (0%) | 0% | 12.5 | 74,397 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2022 | 5,833 | 44,333 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.76 per share. | 28 Sep 2022 | 2,018 | 42,315 (0%) | 0% | 5.8 | 11,624 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 15,000 | 38,500 (0%) | 0% | 0 | Common Stock | |
| Fathom Digital Manufacturi... | Ryan Martin | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. | 14 Apr 2022 | 103,112 | 1,759,028 | - | 7.4 | 764,060 | Class A Common Stock |
| Fathom Digital Manufacturi... | Ryan Martin | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. | 14 Apr 2022 | 82,869 | 1,830,827 | - | 7.4 | 614,059 | Class A Common Stock |
| Fathom Digital Manufacturi... | Ryan Martin | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. | 14 Apr 2022 | 51,556 | 1,779,271 | - | 7.4 | 382,030 | Class A Common Stock |
| Fathom Digital Manufacturi... | Ryan Martin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 103,687 | 103,687 | - | - | Stock Options | |
| Fathom Digital Manufacturi... | Ryan Martin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 50,619 | 1,912,696 | - | - | Class A Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 52,000 | 52,000 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 13,000 | 20,500 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,000 | 23,500 (0%) | 0% | 0 | Common Stock | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.23 per share. | 05 Feb 2022 | 1,022 | 22,478 (0%) | 0% | 5.2 | 5,345 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.11 per share. | 19 Apr 2021 | 10,000 | 17,500 (0%) | 0% | 3.1 | 31,100 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 19 Apr 2021 | 10,000 | 7,500 (0%) | 0% | 25 | 250,000 | Common Stock |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2021 | 10,000 | 84,901 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 57,500 | 57,500 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Ryan Martins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 7,500 | 7,500 (0%) | 0% | 0 | Common Stock |